Volitionrx (VNRX) Invested Capital (2011 - 2025)

Volitionrx has reported Invested Capital for 13 years, with the latest figure at -$28.9 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital fell 16.52% year-over-year to -$28.9 million; the trailing twelve-month figure through Dec 2025 stood at -$28.9 million (down 16.52% YoY), and the FY2025 full-year result was -$28.9 million, down 16.52% from the prior year.
• Invested Capital for Q4 2025 stood at -$28.9 million, up from -$29.5 million in the prior quarter.
• The five-year high for Invested Capital was $34.4 million in Q1 2021, with the low at -$29.5 million in Q3 2025.
• Historically, Invested Capital has averaged -$2.4 million across 5 years, with a median of -$1.3 million in 2022.
• Annual changes were most pronounced in 2021 — Invested Capital soared 189.97% — and 2024, when it tumbled 3717.5%.
• Volitionrx's Invested Capital stood at $17.8 million in 2021, then plunged by 116.91% to -$3.0 million in 2022, then tumbled by 186.17% to -$8.6 million in 2023, then slumped by 188.29% to -$24.8 million in 2024, then dropped by 16.52% to -$28.9 million in 2025.
• The last three Invested Capital figures came in at -$28.9 million (Q4 2025), -$29.5 million (Q3 2025), and -$26.3 million (Q2 2025), per Business Quant data.